Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05384912 · ClinicalTrials.gov registry record
Crowdsourcing an Open COVID-19 Imaging Repository for AI Research
A clinical trial, sponsored by University of Central Florida.
- Completed
- Registry status
- 81
- Enrollment target
NCT05384912: Completed study, sponsored by University of Central Florida.
NCT05384912 is a clinical trial that has completed, run by University of Central Florida. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05384912 has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
The objectives of this project are to (1) assemble a crowdsourced, de-identified radiographic repository; and (2) train and validate existing COVID-NET deep learning diagnostic models.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2020-11-18 |
| Est. Completion | 2025-02-06 |
What the finished NCT05384912 record still lists
NCT05384912 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05384912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05384912 about?
NCT05384912 is a clinical study titled "Crowdsourcing an Open COVID-19 Imaging Repository for AI Research". The objectives of this project are to (1) assemble a crowdsourced, de-identified radiographic repository; and (2) train and validate existing COVID-NET deep learning diagnostic models.
What is the current status of trial NCT05384912?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2020-11-18. Estimated completion is 2025-02-06.
Who is sponsoring clinical trial NCT05384912?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI